z-logo
open-access-imgOpen Access
GRK2 Activation by Receptors: Role of the Kinase Large Lobe and Carboxyl-Terminal Tail
Author(s) -
Rachel SterneMarr,
P. Alex Leahey,
Jamee E. Bresee,
Heather M. Dickson,
Wesley Y. Ho,
Michael J. Ragusa,
Ryan M. Donnelly,
Sarah M. Amie,
Janet A. Krywy,
Elizabeth D. Brookins-Danz,
Somtochukwu C. Orakwue,
Michael Carr,
Kae YoshinoKoh,
Qianzhi Li,
J.J.G. Tesmer
Publication year - 2009
Publication title -
biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.43
H-Index - 253
eISSN - 1520-4995
pISSN - 0006-2960
DOI - 10.1021/bi900151g
Subject(s) - beta adrenergic receptor kinase , g protein coupled receptor kinase , protein kinase domain , g protein coupled receptor , kinase , rhodopsin , phosphorylation , microbiology and biotechnology , receptor , biochemistry , biology , chemistry , biophysics , mutant , retinal , gene
G protein-coupled receptor (GPCR) kinases (GRKs) were discovered by virtue of their ability to phosphorylate activated GPCRs. They constitute a branch of the AGC kinase superfamily, but their mechanism of activation is largely unknown. To initiate a study of GRK2 activation, we sought to identify sites on GRK2 remote from the active site that are involved in interactions with their substrate receptors. Using the atomic structure of GRK2 in complex with Gbetagamma as a guide, we predicted that residues on the surface of the kinase domain that face the cell membrane would interact with the intracellular loops and carboxyl-terminal tail of the GPCR. Our study focused on two regions: the kinase large lobe and an extension of the kinase domain known as the C-tail. Residues in the GRK2 large lobe whose side chains are solvent exposed and facing the membrane were targeted for mutagenesis. Residues in the C-tail of GRK2, although not ordered in the crystal structure, were also targeted because this region has been implicated in receptor binding and in the regulation of AGC kinase activity. Four substitutions out of 20, all within or adjacent to the C-tail, resulted in significant deficiencies in the ability of the enzyme to phosphorylate two different GPCRS: rhodopsin, and the beta(2)-adrenergic receptor. The mutant exhibiting the most dramatic impairment, V477D, also showed significant defects in phosphorylation of nonreceptor substrates. Interestingly, Michaelis-Menten kinetics suggested that V477D had a 12-fold lower k(cat), but no changes in K(M), suggesting a defect in acquisition or stabilization of the closed state of the kinase domain. V477D was also resistant to activation by agonist-treated beta(2)AR. Therefore, Val477 and other residues in the C-tail are expected to play a role in the activation of GRK2 by GPCRs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom